Stevens Capital Management LP Edwards Lifesciences Corp Transaction History

Stevens Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$61.71 - $77.76 $142,611 - $179,703	2,311 Added 18.08%	15,090 $1.15 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $885,329 - $1.19 Million	12,779 New	12,779 $885,000
Q1 2020 Apr 21, 2020	SELL	$52.41 - $81.0 $1.59 Million - $2.46 Million	-30,316 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$71.7 - $82.09 $2.17 Million - $2.49 Million	30,316 New	30,316 $7.07 Million
Q3 2019 Nov 08, 2019	SELL	$61.55 - $75.43 $513,696 - $629,538	-8,346 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$55.74 - $64.41 $465,206 - $537,565	8,346 New	8,346 $1.54 Million
Q4 2017 Feb 13, 2018	SELL	$33.79 - $39.39 $1.02 Million - $1.19 Million	-30,101 Closed	0 $0
Q3 2017 Nov 01, 2017	BUY	$36.29 - $38.83 $1.09 Million - $1.17 Million	30,101	30,101 $3.29 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Stevens Capital Management LP with notifications on news.